Powder: -20°C for 3 years | In solvent: -80°C for 1 year
XMD-17-51 Trifluoroacetate is a pyrimido-diazepinone compound that regulates protein kinases.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 84.00 | |
5 mg | In stock | $ 198.00 | |
10 mg | In stock | $ 322.00 | |
25 mg | In stock | $ 655.00 | |
50 mg | In stock | $ 918.00 | |
100 mg | In stock | $ 1,230.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 233.00 |
Description | XMD-17-51 Trifluoroacetate is a pyrimido-diazepinone compound that regulates protein kinases. |
In vitro | XMD-17-51 Trifluoroacetate is a pyrimido-diazepinone compound proficient in modulating an extensive range of protein kinases, such as MPS1 (TTK), ERK5 (BMK1, MAPK7), various polo kinases, Ack1, Ack2, Abl and its mutants, DCAMKL1, ABL1, DCAMKL2, and many others including Bcr-Abl, GAK, cSrc, and Trk family proteins. This versatility renders it applicable in treating a diverse array of diseases, disorders, or conditions [1]. |
Synonyms | XMD-17-51 Trifluoroacetate (1628614-50-5 free base) |
Molecular Weight | 518.49 |
Formula | C23H25F3N8O3 |
CAS No. | 2436579-93-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 8 mg/ml (19.78 mM)
H2O: 2 mg/ml (4.94 mM)
DMSO: 80 mg/ml (197.78 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
XMD-17-51 Trifluoroacetate 2436579-93-8 Chromatin/Epigenetic PI3K/Akt/mTOR signaling AMPK XMD-17-51 Trifluoroacetate (1628614-50-5 free base) 1628614-50-5 1628614-50-5 free base XMD 17 51 Trifluoroacetate XMD1751 Trifluoroacetate inhibitor inhibit